# Assessment of MDD Management in Andalusia

> **NCT01510886** · — · COMPLETED · sponsor: **AstraZeneca** · enrollment: 5309 (actual)

## Conditions studied

- MDD Management Strategies

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01510886
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-06
- **Primary completion:** 2013-09
- **Final completion:** 2013-09
- **Target enrollment:** 5309 (ACTUAL)
- **Last updated:** 2014-08-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01510886

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01510886, "Assessment of MDD Management in Andalusia". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT01510886. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*